Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2018

Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab

(1) , (1) , (2, 1) , (3, 1) , (3, 1)
1
2
3

Abstract

no abstract

Domains

Life Sciences [q-bio] Human health and pathology Hépatology and Gastroenterology Life Sciences [q-bio] Cancer Life Sciences [q-bio] Pharmaceutical sciences
Fichier principal
Vignette du fichier
Letter_Ramucirumab pour HAL (1).pdf (272.19 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

William Raoul  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-01755511

Submitted on : Friday, March 30, 2018-4:09:19 PM

Last modification on : Thursday, January 20, 2022-10:14:02 AM

Download

Dates and versions

inserm-01755511 , version 1 (30-03-2018)

Identifiers

Cite

Sajida Ibrahim, William Raoul, Thierry Lecomte, Gilles Paintaud, David Ternant. Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab. European Journal of Cancer, 2018, 92, pp.119 - 120. ⟨10.1016/j.ejca.2017.12.004⟩. ⟨inserm-01755511⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-TOURS
146 View
170 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More